FDA.reportPublic FDA data

TAZAROTENE - Food and Drug Administration

Set ID
18da2240-e326-4d63-90cd-d6bb15f662a0
Type
Indexing - product concept
Effective date
2020-06-04
Version
1
Source
DailyMed source

Mapped DailyMed Labels#

Label, Relation, Manufacturer table
LabelRelationManufacturerEffective
These highlights do not include all the information needed to use FABIOR Foam safely and effectively. See full prescribing information for FABIOR Foam. FABIOR (tazarotene) Foam, 0 .1%, for topical use Initial U.S. Approval: 1997Product nameMayne Pharma | DPT Laboratories, Ltd.2026-03-03
These highlights do not include all the information needed to use FABIOR Foam safely and effectively. See full prescribing information for FABIOR Foam. FABIOR (tazarotene) Foam, 0 .1%, for topical use Initial U.S. Approval: 1997Product nameMayne Pharma | DPT Laboratories, Ltd.2026-02-16
These highlights do not include all the information needed to use TAZAROTENE CREAM safely and effectively. See full prescribing information for TAZAROTENE CREAM. TAZAROTENE cream, for topical use Initial U.S. Approval: 1997Product nameSun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.2025-12-19
These highlights do not include all the information needed to use TAZORAC ® Cream safely and effectively. See full prescribing information for TAZORAC ® Cream. TAZORAC ® (tazarotene) cream, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997Product nameAlmirall, LLC2025-11-13
These highlights do not include all the information needed to use TAZORAC ® Gel safely and effectively. See full prescribing information for TAZORAC ® Gel. TAZORAC ® (tazarotene) gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997Product nameAlmirall, LLC2025-11-13
These highlights do not include all the information needed to use TAZAROTENE CREAM safely and effectively. See full prescribing information for TAZAROTENE CREAM. TAZAROTENE cream, for topical use Initial U.S. Approval: 1997Product nameSun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.2025-07-07
These highlights do not include all the information needed to use TAZAROTENE CREAM safely and effectively. See full prescribing information for TAZAROTENE CREAM. TAZAROTENE cream, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997Product nameCosette Pharmaceuticals, Inc. | Cosette Pharmaceuticals NC Laboratories, LLC2025-03-10
These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997Product nameSolaris Pharma Corporation2025-01-02
These highlights do not include all the information needed to use TAZAROTENE CREAM safely and effectively. See full prescribing information for TAZAROTENE CREAM. TAZAROTENE cream, 0.05% for topical use Initial U.S. Approval: 1997Product nameBryant Ranch Prepack2024-11-11
These highlights do not include all the information needed to use Tazarotene Foam safely and effectively. See full prescribing information for Tazarotene Foam. Tazarotene Foam, 0 .1%, for topical use Initial U.S. Approval: 1997Product nameMayne Pharma Inc. | DPT Laboratories, Ltd.2024-06-04
These highlights do not include all the information needed to use TAZAROTENE CREAM safely and effectively. See full prescribing information for TAZAROTENE CREAM. TAZAROTENE cream, 0.05% for topical use Initial U.S. Approval: 1997Product namePadagis Israel Pharmaceuticals Ltd2024-05-31
These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997Product nameBryant Ranch Prepack2024-05-29
These highlights do not include all the information needed to use TAZAROTENE CREAM safely and effectively. See full prescribing information for TAZAROTENE CREAM. TAZAROTENE cream, for topical use Initial U.S. Approval: 1997Product nameMayne Pharma | Cosette Pharmaceuticals NC Laboratories, LLC2024-03-05
These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997Product namePadagis Israel Pharmaceuticals Ltd2024-01-01
PSO THERA Scalp Psoriasis ShampooProduct namePSODEX USA INC | BERKO ILAC VE KIMYA SANAYI ANONIM SIRKETI-SULTANBEYLI SUBESI2023-12-21
Tazarodex Cream Plaque Psoriasis & AcneProduct namePSODEX USA INC | BERKO ILAC VE KIMYA SANAYI ANONIM SIRKETI-SULTANBEYLI SUBESI2023-12-21
These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05%, for topical use Initial U.S. Approval: 1997Product nameCosette Pharmaceuticals, Inc. | Cosette Pharmaceuticals NC Laboratories, LLC2023-11-29
These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.1%, for topical use Initial U.S. Approval: 1997Product nameCosette Pharmaceuticals, Inc. | Cosette Pharmaceuticals NC Laboratories, LLC2023-11-29
These highlights do not include all the information needed to use ARAZLO safely and effectively. See full prescribing information for ARAZLO. ARAZLO ® (tazarotene) lotion, for topical use Initial U.S. Approval: 1997Product nameBausch Health US, LLC | Bausch Health Companies Inc.2023-09-26
011312 NIACINAMIDE 4% / TAZAROTENE 0.05%Product nameSincerus Florida, LLC2020-07-02
These highlights do not include all the information needed to use DUOBRII safely and effectively. See full prescribing information for DUOBRII. DUOBRII ® (halobetasol propionate and tazarotene) lotion, for topical use Initial U.S. Approval: 2019Product nameBausch Health US, LLC | Bausch Health Companies Inc.2020-01-01
These highlights do not include all the information needed to use TAZORAC ® Gel safely and effectively. See full prescribing information for TAZORAC ® Gel. TAZORAC ® (tazarotene) gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997Product nameALMIRALL, LLC2019-08-26
These highlights do not include all the information needed to use TAZORAC ® Cream safely and effectively. See full prescribing information for TAZORAC ® Cream. TAZORAC ® ( tazarotene ) c ream , 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997Product nameALMIRALL, LLC2019-08-01
CLINDAMYCIN 1% / NIACINAMIDE 2% / TAZAROTENE 0.05%Product nameSincerus Florida, LLC2019-05-09
HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%Product nameSincerus Florida, LLC2019-05-09
NIACINAMIDE 4% / TAZAROTENE 0.1%Product nameSincerus Florida, LLC2019-05-09
HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%Product nameSincerus Florida, LLC2019-05-06
NIACINAMIDE 4% / TAZAROTENE 0.05%Product nameSincerus Florida, LLC2019-04-23
NIACINAMIDE 4% / TAZAROTENE 0.1%Product nameSincerus Florida, LLC2019-04-23
These highlights do not include all the information needed to use TAZORAC ® Gel safely and effectively. See full prescribing information for TAZORAC ® Gel. TAZORAC ® (tazarotene) gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997Product nameAllergan, Inc.2018-04-16
Physicians Total Care, Inc. human prescription drug labelProduct namePhysicians Total Care, Inc.2010-10-22